Acadian Asset Management LLC Grows Stock Position in Medifast Inc $MED

Acadian Asset Management LLC increased its stake in shares of Medifast Inc (NYSE:MED) by 6.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 411,101 shares of the specialty retailer’s stock after purchasing an additional 25,378 shares during the period. Acadian Asset Management LLC owned 3.74% of Medifast worth $5,769,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Nisa Investment Advisors LLC lifted its stake in shares of Medifast by 370.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,144 shares of the specialty retailer’s stock worth $30,000 after purchasing an additional 1,688 shares during the period. Strs Ohio purchased a new stake in shares of Medifast in the first quarter valued at $78,000. CWM LLC increased its stake in Medifast by 564.6% in the second quarter. CWM LLC now owns 7,457 shares of the specialty retailer’s stock valued at $105,000 after purchasing an additional 6,335 shares during the last quarter. Russell Investments Group Ltd. increased its stake in Medifast by 114.1% in the first quarter. Russell Investments Group Ltd. now owns 19,514 shares of the specialty retailer’s stock valued at $267,000 after purchasing an additional 10,401 shares during the last quarter. Finally, Allianz Asset Management GmbH purchased a new position in Medifast during the second quarter worth about $307,000. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Weiss Ratings restated a “sell (d)” rating on shares of Medifast in a research note on Wednesday, October 8th. Wall Street Zen cut Medifast from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $16.50.

Medifast Price Performance

Shares of MED stock opened at $11.49 on Friday. The firm has a fifty day moving average of $13.17 and a two-hundred day moving average of $13.50. The firm has a market cap of $126.29 million, a P/E ratio of 35.91 and a beta of 0.82. Medifast Inc has a 1-year low of $11.25 and a 1-year high of $21.98.

Medifast (NYSE:MED) last issued its earnings results on Monday, November 3rd. The specialty retailer reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.20). Medifast had a return on equity of 2.00% and a net margin of 0.76%.The firm had revenue of $89.41 million during the quarter, compared to analyst estimates of $84.10 million. Medifast has set its Q4 2025 guidance at -1.250–0.70 EPS. On average, sell-side analysts expect that Medifast Inc will post 0.51 EPS for the current year.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.